Translate
Text Highlighter

Bookmark

PDF

Share

Report a problem
AMICUS AI
Citation Codes
Equivalent Citations
citation codes
Attorney(S)
Judges
Are you a practicing lawyer?
Enhance your digital presence and reach by creating a Casemine profile.
Upload pleading to use the new AI search
Cites
Cited by
Citation Codes
Equivalent Citations
citation codes
Attorney(S)
Judges

KCI Licensing Inc & Ors v. Smith & Nephew Plc & Ors

Smart Summary

Factual and Procedural Background

The Claimants (collectively "Company A") allege that the Defendants (collectively "Company B") infringed two European Patents (UK) concerning wound drainage equipment and wound drainage canisters ("the Patents"). Company B denies infringement and counterclaims for revocation. Company A did not defend the validity of the broader claims, limiting issues to specific claims of each Patent.

The Patents relate to apparatus used in Negative Pressure Wound Therapy ("NPWT"), a treatment involving sealed wound dressings and vacuum application to promote healing. The technique was pioneered by researchers at The University, who filed a related International Patent Application ("Argenta"), which forms principal prior art.

This is the second patent action between the parties concerning NPWT apparatus. In a previous action, Company A and The University sued Company B for infringement of a related patent, resulting in mixed findings on validity and infringement, with appeals and further revocation proceedings. Company A’s interim injunction application in the present case was refused.

The Patents claim improvements over Argenta, primarily involving a disposable wound fluids canister integrated in a compact, self-contained apparatus. The dispute includes detailed examination of patent specifications, claims, expert evidence, priority entitlement, and infringement of specific claims.

Legal Issues Presented

  1. Are the Patents entitled to the claimed priority date given the standing of the applicants and successors in title?
  2. Are claims 5 of the first Patent and claims 7 and 8 of the second Patent valid, particularly regarding inventive step over Argenta and other prior art?
  3. Do Company B’s products infringe the claims in issue, including interpretation of specific claim features?
  4. Does section 60(2) of the Patents Act 1977 apply to supplies of components intended to put the invention into effect?

Arguments of the Parties

Company A's Arguments

  • Company A contends that it is entitled to claim priority through Company A’s status as successor in title to the original inventor by virtue of a confidentiality agreement and a specific assignment.
  • Company A argues that the skilled team would implement Argenta and that the use of reticulated foam and gel-forming substances as claimed is not obvious.
  • Company A asserts that Company B’s products infringe the relevant claims, including under section 60(2) for supplies of pumps and canisters intended to be used with foam dressings.
  • Company A submits that “deactivated” in the claims means rendering the pump sufficiently less active, not necessarily switched off.

Company B's Arguments

  • Company B denies entitlement to priority by Company A, arguing the confidentiality agreement and assignment did not transfer rights effectively.
  • Company B argues that the use of reticulated foam and gel-forming substances would have been obvious to the skilled team based on common general knowledge or routine searches.
  • Company B contends that the claim construction should be restrictive, for example requiring the canister to be mostly within the housing and the filter to be physically part of the canister outlet.
  • Company B disputes infringement, particularly on the interpretation of “deactivated” and the application of section 60(2) regarding intention to put the invention into effect.

Table of Precedents Cited

Precedent Rule or Principle Cited For Application by the Court
Edwards Lifesciences AG v Cook Biotech Inc [2009] EWHC 1304 (Pat) Interpretation of priority entitlement under Paris Convention and EPC; "successor in title" must be to the invention at the time of filing. Supported conclusion that Company A was successor in title by virtue of confidentiality agreement and assignment, entitling priority claim.
Performing Rights Society Ltd v London Theatre of Varieties Ltd [1924] AC 1 Equity treats assignments of future property as contracts to assign when property comes into existence. Considered but distinguished as not applying to patentable inventions under Patents Act 1977.
Yeda Research and Development Co Ltd v Rhone-Poulenc Rorer International Holdings Inc [2007] UKHL 43 Ownership and entitlement to patent rights; importance of legal title to invention. Supported analysis of ownership and priority entitlement under section 7(2) of Patents Act 1977.
Legal Board of Appeal Case J19/87 Burr-Brown /Assignment [1988] EPOR 350 Assignment of invention and patent application with covenant of further assurance sufficient for priority claim. Supported conclusion that equitable interest suffices for successor in title under international treaties.
Beloit Technologies Inc v Valmet Paper Machinery Inc [1997] RPC 489 Definition and scope of common general knowledge in patent law. Adopted as correct exposition of common general knowledge standard.
Raychem Corp's Patents [1998] RPC 31 Common general knowledge as the technical background of the skilled person, including material regarded as reliable. Applied to assess the skilled team’s knowledge relevant to inventive step.
Nutrinova Nutrition Specialties & Food Ingredients GmbH v Scanchem UK Ltd [2001] FSR 42 Consideration of information acquired routinely by skilled person in obviousness analysis. Referenced in discussion of common general knowledge versus routine acquisition.
Novartis AG v Ivax Pharmaceuticals UK Ltd [2006] EWHC 2506 (Pat) Distinction between common general knowledge and information acquired by routine search. Applied in assessing evidence of knowledge of gel-forming substances and reticulated foam.
Ivax Pharmaceuticals UK Ltd v Akzo Nobel NV [2006] EWHC 1089 (Pat) Similar principles on common general knowledge and routine acquisition of information. Considered in evaluating expert evidence on materials knowledge.
Generics (UK) Ltd v Daiichi Pharmaceutical Co Ltd [2008] EWHC 2413 (Pat) Clarification of common general knowledge and its role in inventive step. Quoted to distinguish common general knowledge from information acquired subsequently.
Cranway Ltd v Playtech Ltd [2009] EWHC 1588 (Pat) Interpretation of intention under section 60(2) of the Patents Act 1977. Supported finding that relevant intention is that of the person supplied, not the supplier.
Windsurfing International Inc v Tabur Marine (Great Britain) Ltd [1985] RPC 59 Structured approach to assessing obviousness. Applied as framework for inventive step analysis.
Pozzoli v BDMO SA [2007] EWCA Civ 588 Restatement of Windsurfing approach to obviousness. Applied in assessing inventive step of claims in issue.
H. Lundbeck A/S v Generics (UK) Ltd [2008] EWCA Civ 311 Factors relevant to obviousness including motive and expectation of success. Considered in weighing obviousness arguments.
Conor Medsystems Inc v Angiotech Pharmaceuticals Inc [2008] UKHL 49 Obviousness principles and assessment of inventive step. Referenced in evaluating inventive step issues.
M lnlycke AB v Proctor & Gamble Co (No 5) [1994] RPC 49 Requirement for expert evidence to establish obviousness. Applied in rejecting obviousness argument based on prior art without expert support.
Panduit Corp v Band-It Co Ltd [2002] EWCA Civ 465 Requirement for expert evidence in obviousness findings. Applied in context of obviousness assessment of claim 7 over Karakelle.
Kirin Amgen Inc v Hoechst Marion Roussel Ltd [2004] UKHL 46 Principles of patent claim construction. Guided claim construction analysis in this case.

Court's Reasoning and Analysis

The court first addressed entitlement to priority. It applied the relevant provisions of the Patents Act 1977, the European Patent Convention, and the Paris Convention, confirming that priority can only be claimed by the original applicant or a successor in title at the time of filing. The court found that Company A was the successor in title to the inventor by virtue of a confidentiality agreement which effectively assigned legal title to inventions made during employment, and also, more probably than not, by a specific assignment executed shortly after the priority application was filed. The court rejected Company B’s arguments that the confidentiality agreement did not effect a valid assignment, distinguishing the legal treatment of patentable inventions from other future property. The court further concluded that the subsidiary named as co-applicant for the UK national phase was not a co-applicant for the European patent, but even if it was, this would not adversely affect the priority claim.

Turning to the skilled team, the court identified it as comprising a clinician experienced in wound care and a medical device design engineer, with the clinician leading decisions on clinical suitability. The court carefully examined the common general knowledge of both components of the team, relying on expert evidence. It concluded that reticulated foam was known to the design engineer but not known in medical applications, and gel-forming substances were not common general knowledge among design engineers in medical device design.

On obviousness, the court applied the established Windsurfing/Pozzoli four-step test. It found that the skilled team would implement Argenta but with caution, particularly regarding foam dressings, due to prevailing clinical concerns. The court held that it was not obvious to use reticulated foam as a wound dressing because the clinician would reject it for clinical reasons, and the design engineer would not identify it as suitable. Similarly, it was not obvious to include a gel-forming substance in the disposable canister to prevent splashing as this was not common general knowledge, and there was no evidence that a design engineer would as a matter of routine research this solution.

Regarding claim construction, the court interpreted key claim features purposively. It construed the "recess in the housing" broadly to include a peripheral recess that aligns the canister, as found in the accused product, rejecting a restrictive interpretation requiring the canister to be mostly within the housing. The court construed "deactivated" as rendering the pump sufficiently less active to prevent overfilling, not necessarily switched off. It also construed the "outlet incorporating a bacterial filter" to allow the filter to be located anywhere along the outlet tubing, not necessarily physically part of the canister body.

On infringement, the court found that Company B’s accused products fell within the claims as construed. It held that sales of pumps and canisters intended to be used with foam dressings infringed claim 5 of the first Patent and claims 7 and 8 of the second Patent pursuant to section 60(2) of the Patents Act 1977. The court determined that the relevant intention to put the invention into effect is that of the person supplied, not the supplier. Since purchasers bought components for use with both foam and gauze dressings, and Company B knew or it was obvious that the components were intended for use with foam dressings, infringement was established. However, for claim 7 of the second Patent, the court found no infringement by sales of canisters lacking clamp means on the inlet tube because the use of clamps was not intended by Company B but happened incidentally.

Holding and Implications

DISMISSED the Defendants’ counterclaims for revocation of the claims in issue and found infringement by the Defendants of claim 5 of the first Patent and claims 7 and 8 of the second Patent pursuant to section 60(2) of the Patents Act 1977 in respect of certain products.

The Patents are entitled to the claimed priority date. The validity attacks on the claims in issue fail. The Defendants’ accused products fall within the scope of these claims as properly construed. The Defendants infringed the first Patent by sales of the GO pumps and canisters, and infringed the second Patent by sales of the EZ canisters but not the GO canisters. No new precedent was established; the decision applies the settled principles of priority, claim construction, obviousness, and infringement under UK patent law.

To access the original judgment, please Sign In or Subscribe.

KCI Licensing Inc & Ors v Smith & Nephew Plc & Ors

Contains public sector information licensed under the Open Justice Licence v1.0.

Use AI to get other relevant cases.

Comments

KCI Licensing Inc & Ors v Smith & Nephew Plc & Ors
(Jun 23, 2010)